Junji Yatsuda

472 total citations
26 papers, 304 citations indexed

About

Junji Yatsuda is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Junji Yatsuda has authored 26 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Oncology and 9 papers in Surgery. Recurrent topics in Junji Yatsuda's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (8 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Junji Yatsuda is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (8 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Junji Yatsuda collaborates with scholars based in Japan, United States and Poland. Junji Yatsuda's co-authors include Tomomi Kamba, Takanobu Motoshima, Yoshihiro Komohara, Yutaka Sugiyama, Yoji Murakami, Masatoshi Eto, Kazuhiro Ishizaka, Yasuhiro Yoshimura, Ryuichi Nishinakamura and Hidetake Kurihara and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Junji Yatsuda

25 papers receiving 302 citations

Peers

Countries citing papers authored by Junji Yatsuda

Since Specialization

Citations

This map shows the geographic impact of Junji Yatsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Yatsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Yatsuda more than expected).

Fields of papers citing papers by Junji Yatsuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Yatsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Yatsuda. The network helps show where Junji Yatsuda may publish in the future.

Co-authorship network of co-authors of Junji Yatsuda

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Yatsuda. A scholar is included among the top collaborators of Junji Yatsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Yatsuda. Junji Yatsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potential protumor function of CD74 in clear cell renal cell carcinoma 2024 ·Human Cell ·(unknown), Hiromu Yano, (unknown), (unknown), (unknown), (unknown), Takanobu Motoshima, Junji Yatsuda, Shigeyuki Esumi, Yuji Miura, Tomomi Kamba, Yoshihiro Komohara	2
2	Enhancing thin slice 3D T2-weighted prostate MRI with super-resolution deep learning reconstruction: Impact on image quality and PI-RADS assessment 2024 ·Magnetic Resonance Imaging ·(unknown), Takeshi Nakaura, Naoki Kobayashi, Hiroyuki Uetani, Yasunori Nagayama, Masafumi Kidoh, Junji Yatsuda, (unknown), Tomomi Kamba, (unknown), Toshinori Hirai	1
3	The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophages 2024 ·Clinical & Translational Immunology ·Cheng Pan, Yukio Fujiwara, Hiromu Yano, (unknown), (unknown), Lianbo Li, Yuji Miura, Takanobu Motoshima, Shigeyuki Esumi, Junji Yatsuda, Taizo Hibi, Tomomi Kamba, Yoshihiro Komohara	1
4	Predictive value of CXCL10 for the occurrence of immune‐related adverse events in patient with renal cell carcinoma 2023 ·Microbiology and Immunology ·Yuji Miura, Takanobu Motoshima, (unknown), Hiromu Yano, (unknown), Cheng Pan, Shinji Urakami, Keiichi Kinowaki, Hirotake Tsukamoto, (unknown), Yoji Murakami, Junji Yatsuda, Yukio Fujiwara, Tomomi Kamba, Yoshihiro Komohara	7
5	Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma 2023 ·IJU Case Reports ·(unknown), Takanobu Motoshima, Junji Yatsuda, (unknown), (unknown), Yoji Murakami, (unknown), Yutaka Sugiyama, Ryoji Yoshida, Hideki Nakayama, Tomomi Kamba	2
6	Dysfunction of sinus macrophages in tumor‐bearing host induces resistance to immunotherapy 2023 ·Cancer Science ·(unknown), Cheng Pan, Yukio Fujiwara, Yoshihiro Komohara, Hiromu Yano, Yoichi Saito, Masamichi Sugimoto, Daiko Wakita, Takanobu Motoshima, Yoji Murakami, Junji Yatsuda, (unknown), Shinya Suzu, Kenichi Asano, Koji Tamada, Tomomi Kamba	6
7	Efficacy of avelumab plus axitinib for advanced renal cell carcinoma as late-line therapy: A case report 2022 ·Urology Case Reports ·(unknown), (unknown), Takanobu Motoshima, Yoji Murakami, Junji Yatsuda, Tomomi Kamba	0
8	Subcapsular renal hematoma after ureterorenoscopy 2022 ·IJU Case Reports ·(unknown), Junji Yatsuda, (unknown), (unknown), (unknown), Takanobu Motoshima, Yoji Murakami, (unknown), Yutaka Sugiyama, Tomomi Kamba	1
9	Anti-Cancer Immune Reaction and Lymph Node Macrophage; A Review from Human and Animal Studies 2021 ·SHILAP Revista de lepidopterología ·Yoshihiro Komohara, (unknown), Kenichi Asano, Yukio Fujiwara, Junji Yatsuda, Tomomi Kamba	2
10	HLA-DR and CD74 Expression and the Immune Microenvironment in Renal Cell Carcinoma 2021 ·Anticancer Research ·Yuji Miura, (unknown), Junji Yatsuda, Takanobu Motoshima, (unknown), Koichi Suyama, Naoko Inoshita, Keiichi Kinowaki, Shinji Urakami, Tomomi Kamba, Yoshihiro Komohara	9
11	High T-cell infiltration in tumor tissue and younger age predict the response to pembrolizumab in recurrent urothelial cancer 2021 ·Medical Molecular Morphology ·(unknown), Yoshihiro Komohara, Yuji Miura, (unknown), (unknown), Takuya F. Segawa, Takanobu Motoshima, Yoji Murakami, Junji Yatsuda, (unknown), Yutaka Sugiyama, Yoshiteru Jinnouchi, Tomomi Kamba	6
12	Anti-cancer Immune Reaction and Lymph Node Macrophage; A Review from Human and Animal Studies 2021 ·Preprints.org ·Yoshihiro Komohara, (unknown), Kenichi Asano, Yukio Fujiwara, Junji Yatsuda, Tomomi Kamba	1
13	Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort 2020 ·International Journal of Urology ·Toru Kanno, Takahiro Inoue, Katsuhiro Ito, (unknown), Hitoshi Yamada, Mutsushi Kawakita, Masato Fujii, Yosuke Shimizu, Junji Yatsuda, Seiji Moroi, Yasumasa Shichiri, Toshiya Akao, (unknown), Takashi Kobayashi, Osamu Ogawa	8
14	Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched‐pair comparison in a multicenter cohort in Japan 2020 ·International Journal of Urology ·Toru Kanno, Takahiro Inoue, Mutsushi Kawakita, Katsuhiro Ito, (unknown), Hitoshi Yamada, Masashi Kubota, Masato Fujii, Yosuke Shimizu, Junji Yatsuda, (unknown), Seiji Moroi, Yasumasa Shichiri, Toshiya Akao, (unknown), Ryoichi Saito, Takashi Kobayashi, Osamu Ogawa	6
15	Manipulation of Nephron-Patterning Signals Enables Selective Induction of Podocytes from Human Pluripotent Stem Cells 2019 ·Journal of the American Society of Nephrology ·Yasuhiro Yoshimura, Atsuhiro Taguchi, Shunsuke Tanigawa, Junji Yatsuda, Tomomi Kamba, Satoru Takahashi, Hidetake Kurihara, Masashi Mukoyama, Ryuichi Nishinakamura	53
16	Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4 ⁺ T cells expressing converged T-cell receptor genes in vitro 2017 ·OncoImmunology ·(unknown), (unknown), Poh Yin Yew, Isao Fukuda, (unknown), Hiroyuki Kishi, Hiroshi Hamana, Masatoshi Hirayama, Junji Yatsuda, Atsushi Irie, Satoru Senju, Eiji Yuba, Tomomi Kamba, Masatoshi Eto, Hideki Nakayama, Yasuharu Nishimura	12
17	C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways 2015 ·Oncology Reports ·Yoshihiro Maeda, Yoshiaki Kawano, Yoshihiro Wada, Junji Yatsuda, Takanobu Motoshima, Yoji Murakami, Ken Kikuchi, Takahisa Imamura, Masatoshi Eto	44
18	Identification of immunogenic LY6K long peptide encompassing both CD4⁺and CD8⁺T-cell epitopes and eliciting CD4⁺T-cell immunity in patients with malignant disease 2014 ·OncoImmunology ·Yusuke Tomita, Akira Yuno, Hirotake Tsukamoto, Satoru Senju, Yasuhiro Kuroda, Masatoshi Hirayama, (unknown), Junji Yatsuda, (unknown), Atsushi Irie, Akinobu Hamada, Hirofumi Jono, Koji Yoshida, Takuya Tsunoda, Yataro Daigo, Hirotsugu Kohrogi, Yoshihiro Yoshitake, Yusuke Nakamura, Masanori Shinohara, Yasuharu Nishimura	17
19	Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor 2013 ·Clinical Cancer Research ·Yusuke Tomita, Akira Yuno, Hirotake Tsukamoto, Satoru Senju, Yasuhiro Kuroda, Masatoshi Hirayama, Atsushi Irie, Kenta Kawahara, Junji Yatsuda, Akinobu Hamada, Hirofumi Jono, Koji Yoshida, Takuya Tsunoda, Hirotsugu Kohrogi, Yoshihiro Yoshitake, Yusuke Nakamura, Masanori Shinohara, Yasuharu Nishimura	50
20	Establishment of HLA-DR4 Transgenic Mice for the Identification of CD4+ T Cell Epitopes of Tumor-Associated Antigens 2013 ·PLoS ONE ·Junji Yatsuda, Atsushi Irie, Kumiko Harada, (unknown), Hirotake Tsukamoto, Satoru Senju, Yusuke Tomita, Akira Yuno, Masatoshi Hirayama, (unknown), Naoki Takeda, Isao Shibuya, Shinji Sogo, Fumihiro Fujiki, Haruo Sugiyama, Masatoshi Eto, Yasuharu Nishimura	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact